• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDN - 21:甲状腺髓样癌可能的肿瘤标志物。

PDN-21: possible tumor marker for medullary thyroid carcinoma.

作者信息

Takami H, Shikata J, Horie H, Sekine K, Ito K

机构信息

First Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.

出版信息

J Surg Oncol. 1990 Aug;44(4):205-7. doi: 10.1002/jso.2930440403.

DOI:10.1002/jso.2930440403
PMID:2385096
Abstract

The plasma level of PDN-21 was measured by RIA in 10 patients with medullary thyroid carcinoma (MTC). All 10 patients with MTC had extremely elevated PDN-21 levels. The correlations between PDN-21, calcitonin gene-related peptide, and calcitonin, (all of which are calcitonin gene products) were significant (P less than .001) in the 10 MTC patients. This study suggests that PDN-21, as well as calcitonin, may be a useful marker for the detection of patients with MTC.

摘要

采用放射免疫分析法测定了10例甲状腺髓样癌(MTC)患者血浆中PDN - 21的水平。所有10例MTC患者的PDN - 21水平均极度升高。在这10例MTC患者中,PDN - 21、降钙素基因相关肽和降钙素(所有这些都是降钙素基因产物)之间的相关性显著(P小于0.001)。本研究表明,PDN - 21以及降钙素可能是检测MTC患者的有用标志物。

相似文献

1
PDN-21: possible tumor marker for medullary thyroid carcinoma.PDN - 21:甲状腺髓样癌可能的肿瘤标志物。
J Surg Oncol. 1990 Aug;44(4):205-7. doi: 10.1002/jso.2930440403.
2
Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.
J Endocrinol Invest. 1992 Feb;15(2):93-8. doi: 10.1007/BF03348671.
3
Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma.降钙素和PDN-21作为MEN-2家族甲状腺髓样癌筛查中的肿瘤标志物。
Eur J Cancer. 1992;28(2-3):341-5. doi: 10.1016/s0959-8049(05)80050-4.
4
Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
J Clin Endocrinol Metab. 1985 Dec;61(6):1133-7. doi: 10.1210/jcem-61-6-1133.
5
Measurement of serum PDN-21 (Katacalcin) levels by radioimmunoassay in patients with various thyroid diseases.
Exp Clin Endocrinol. 1994;102(5):370-3. doi: 10.1055/s-0029-1211306.
6
PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.
Henry Ford Hosp Med J. 1992;40(3-4):296-8.
7
Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.与甲状腺髓样癌相比,败血症中循环中的降钙素原及其裂解产物。
Eur J Endocrinol. 2002 Dec;147(6):727-31. doi: 10.1530/eje.0.1470727.
8
Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.降钙素基因相关肽作为甲状腺髓样癌的肿瘤标志物
Int Surg. 1992 Jul-Sep;77(3):181-5.
9
Utility of proGRP as a tumor marker in the medullary thyroid carcinoma.胃泌素释放肽前体(ProGRP)作为甲状腺髓样癌肿瘤标志物的效用。
Clin Chem Lab Med. 2017 Mar 1;55(3):441-446. doi: 10.1515/cclm-2016-0572.
10
Salmon and human calcitonin-like peptides in man.人体内的鲑鱼降钙素样肽和人降钙素样肽
Clin Endocrinol (Oxf). 1984 Mar;20(3):253-9. doi: 10.1111/j.1365-2265.1984.tb00081.x.

引用本文的文献

1
Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.甲状腺髓样癌与2型多发性内分泌腺瘤病
Endocr Pathol. 2003 Summer;14(2):123-31. doi: 10.1385/ep:14:2:123.
2
Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.
J Endocrinol Invest. 1992 Feb;15(2):93-8. doi: 10.1007/BF03348671.